Status:
COMPLETED
Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic
Lead Sponsor:
Drexel University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Bulimia Nervosa
Bulimia; Atypical
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In the current study, the investigators will revise our existing 10-session group RRT treatment manual to specifically address the challenges in building social support and enhancing both momentary an...
Eligibility Criteria
Inclusion
- Have experienced 12 or more loss of control episodes within the previous 3 months
- Have a BMI above 18.5
- Are located in the US and willing/able to participate in remote treatment and assessments
- Are able to give consent
Exclusion
- Are unable to fluently speak, write and read English
- Have a BMI below 18.5
- Are receiving treatment for an eating disorder
- Require immediate treatment for medical complications as a result of eating disorder symptoms
- Have a mental handicap, or are experiencing other severe psychopathology that would limit the participants' ability to comply with the demands of the current study (e.g. severe depression with suicidal intent, active psychotic disorder)
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04661410
Start Date
December 1 2020
End Date
September 15 2021
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Drexel University, Stratton Hall
Philadelphia, Pennsylvania, United States, 19104